Sydney, Australia, Aug 16, 2019 - (ABN Newswire) - Anatara Lifesciences Ltd's (ASX:ANR.AX - News) CEO, Steve Lydeamore will be presenting to investors at a Monsoon Communications Twilight Investor Briefing event in Melbourne next week. Investors interested in attending this presentation are invited to reach out.
Monsoon Communications Twilight Investor Briefing
Steve will provide an update on Anatara's work in gastrointestinal health for both humans and animals, alongside AdAlta Ltd:
* Thursday 22nd August 2019
* 4.15pm for 4.30pm
* FB Rice Boardroom, Level 14, 90 Collins Street, Melbourne
About Anatara Lifesciences Ltd:
Anatara Lifesciences (ASX:ANR.AX - News) is developing and commercialising innovative, evidence-based products for gastrointestinal health where there is significant unmet need. Anatara is a life sciences company with expertise in developing products for animal and human health. Anatara is focused on building a pipeline of human gastrointestinal health products. Underlying this product development program is our commitment to delivering real outcomes for patients and strong value for our shareholders. For more information, please visit www.anataralifesciences.com.
Investor and Media inquiries Steven Lydeamore Chief Executive Officer Anatara Lifesciences Ltd T: +61-438-027-172 E: email@example.com Sue MacLeman Chair Anatara Lifesciences Ltd T: +61-437-211-200 E: firstname.lastname@example.org
Anatara Lifesciences Ltd
Copyright (C) 2019 ABN Newswire. All rights reserved.